← FDA Drug Approvals (Drugs@FDA)
FLUORESCEIN SODIUM
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: BPI LABS · Approved 2026-04-30
Drug application
- FDA Application #
ANDA220046- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- FLUORESCEIN SODIUM
- Generic name
- Fluorescein Sodium
- Active ingredients
- FLUORESCEIN SODIUM
- Dosage form
- INJECTABLE
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Sponsor
- BPI LABS
- First approval
- 2026-04-30
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown